Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms

European Neurology

Volumn 42, Issue 1, 1999, Pages 41-48

  Komatsu, Naoya ^a   Kodama, Kazuhiro ^a   Yamanouchi, Naoto ^a   Okada, Shin Ichi ^a   Noda, Shingo ^a   Nawata, Yasushi ^a   Takabayashi, Katsuhiko ^a   Iwamoto, Itsuo ^a   Saito, Yasushi ^a   Uchida, Yoshitaka ^a   Ito, Hisashi ^a   Yoshikawa, Kyosan ^b   Sato, Toshio ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Attentional deficits; Positron emission tomography; Psychiatric symptom; Regional cerebral metabolic rate for glucose; Systemic lupus erythematosus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE METABOLISM; HUMAN; MENTAL DISEASE; METABOLIC RATE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ATTENTION; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; FUNCTIONAL LATERALITY; GLUCOSE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032979397     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008067     Document Type: Article

References (37)

1. Richardson EP: Systemic lupus erythematosus; in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology; Neurological Manifestations of Systemic Disease Part II. Amsterdam, Elsevier, 1980, pp 273-293.
2. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB: Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 1976;55:323-339.
3. Pinching AJ, Travers RL, Hughes GRV, Jones T, Moss S: Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1978;i:898-900.
4. Awada HH, Mamo HL, Luft AG, Ponsin JC, Kahn MF: Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement. J Neurol Neurosurg Psychiatry 1987;50:1597-1601.
5. Volkow ND, Warner N, Mcintyre R, Valentine A, Kulkarni M, Mullani N, Gould L: Cerebral involvement in systemic lupus erythematosus. Am J Physiol Imaging 1988;3:91-98.
6. Kushner MJ, Tobin M, Fazekas F, Chawluk J, Jamieson D, Freundlich B, Grenell S, Freeman L, Reivich M: Cerebral blood flow variations in CNS lupus. Neurology 1990;40:99-102.
7. Stoppe G, Wildhagen K, Seidel JW, Meyer G-J, Schober O, Heintz P, Kunkel H, Deicher H, Hundeshagen H: Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990;40:304-308.
8. Carbotte RM, Denburg SD, Denburg JA, Nahmias C, Garnett ES: Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1992;55: 1054-1059.
9. Rubbert A, Marienhagen J, Pirner K, Manger B, Grebmeier J, Engelhardt A, Wolf F, Kalden JR: Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1253-1262.
10. Emmi L, Bramati M, De Cristofaro MTR, Mascalchi M, Dal Pozzo G, Marconi GP, Massai G, Passaleva A: MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993;11:13-20.
11. Kodama K, Okada S, Hino T, Takabayashi K, Nawata Y, Uchida Y, Yamanouchi N, Komatsu N, Ikeda T, Shinoda N, Murakami A, Sakamoto T, Sato T: Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psychiatry 1995;58:307-311.
12. Carbotte RM, Denburg SD, Denburg JA: Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986;174: 357-364.
13. Hay EM, Black D, Huddy A, Creed F, Tomenson B, Bernstein RM, Holt PJ: Psychiatric disorders and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35:411-416.
14. Fisk JD, Eastwood B, Sherwood G, Hanly JG: Patterns of cognitive impairment in patients with systemic lupus erythematosus. Br J Rheumatol 1993;32:458-462.
15. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640.
17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 revised. Washington, American Psychiatric Press, 1987.
18. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Benton AL, Hamsher K, Varney NR, Spreen O: Contributions to Neuropsychological Assessment. New York, Oxford University Press, 1983.
20. Spreen O, Strauss E: A Compendium of Neuropsychological Tests. Administration, Norms, and Commentary. New York, Oxford University Press, 1991.
21. Lezak MD: Neuropsychological Assessment, ed 2. New York, Oxford University Press, 1983.
22. Kanno I, Miura S, Uemura K, Murakami M, Hirose Y, Takahashi S: High performance positron emission tomograph: HEADTOME III. Jpn J Nucl Med 1984;21:921-932.
23. Matsui T, Hirano A: An Atlas of the Human Brain for Computerized Tomography. Tokyo, Igaku-Shoin, 1978.
24. 18F]2-fluoro-2-deoxy-D-glucose: Validation of method, Ann Neurol 1979; 6:371-388.
25. Brooks RA: Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 1982;23:538-539.
26. Mesulam MM: Principles of Behavioral Neurology; Patterns in Behavioral Neuroanatomy: Association Areas, the Limbic system, and hemispheric Specialization. Philadelphia, Davis Co, 1985, pp 1-70.
27. Posner MI, Petersen SE: The attention system of the human brain. Annu Rev Neurosci 1990; 13:25-42.
28. Pardo JV, Fox PT, Raichle ME: Localization of a human system for sustained attention by positron emission tomography. Nature 1991; 349:61-64.
29. Pardo JV, Pardo PJ, Janer KW, Raichle ME: The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 1990;87: 256-259.
30. Bresnihan B, Hohmeister R, Cutting J, Travers RL, Waldburger M, Black C, Jones T, Hughes GRV: The neuropsychiatric disorder in systemic lupus erythematosus: Evidence for both vascular and immune mechanisms. Ann Rheum Dis 1979;38:301-306.
31. Devinsky O, Petito CK, Alonso DR: Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380-384.
32. Atkins CJ, Kondon JJ, Quismorio FP, Friou GJ: The choroid plexus in systemic lupus erythematosus. Ann Intern Med 1972;76:65-72.
33. Bluestein HG, Williams GW, Steinberg AD: Cerebrospinal fluid antibodies to neuronal cells: Association with neuropsychiatrie manifestations of systemic lupus erythematosus. Am J Med 1981;70:240-246.
34. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB: Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317: 265-271.
35. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T: Interferon-alpha in lupus psychosis. Arthritis Rheum 1992;35:417-422.
36. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, Hughes GRV: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-399.
37. Love PE, Santoro SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: Prevalence and clinical significance. Ann Intern Med 1990;112: 682-698.